I read the Ethical Equities piece yesterday and following reading the string of comments in here today, feel compelled to post.
I'm interested in what timeframe 'for now' is deemed to be in respect to price sensitive developments having dried up?
Things that wouldn't be out of the question:
* Granting of Australian MC licenses - recent AU name change and land purchase make it apparent this may be sooner rather than later
* European announcements following company focus and investment having only just begun in that region - considering Paul's experience and relationships in that part of the world, not so silly to think he wouldn't have invested time and money if there wasn't low hanging fruit
* Larger distro deals struck in the Japanese market and Asian focused announcements - Recently being stocked in Tokyo domestic airport would seem tip of the iceberg there, following Paul's recent visit to the Asian Hemp Summit, what country is next?
* Topical news flow and halo potential from Nth America - we wake up to this daily. Even if something positive happens for another of the big CBD companies, the continually rising tide should help to lift all boats in an early stage developing market. Also understand potential for lowering of tides i.e. negative FDA/WHO related news and competitor entry but things are undeniably progressing in a more positive than negative direction as % growth for $CWEB, $CVSI shows
* New Zealand - smaller market though with importation recently announced by Elixinol, distribution again must be on the cards
* Latin American expansion - hinted at in Ethical Equities piece and noted as a share price driver
Not to mention it is of course only 2 months until further anticipated growth is announced in quarterly reporting and the fact that there is a net cash position of $42 million for the company to utilise if an opp presents itself.
Can we be sure there are no short term growth catalysts?
IMO of course, always keen to hear the depth in others thoughts
- Forums
- ASX - By Stock
- EXL
- Ann: FY 2018 Investor Results Presentation
Ann: FY 2018 Investor Results Presentation, page-10
-
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EXL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.605M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $1.605K | 321.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 6265944 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 14532474 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3797 | 4.490 |
1 | 8000 | 4.480 |
2 | 6000 | 4.470 |
1 | 358 | 4.460 |
3 | 3424 | 4.450 |
Price($) | Vol. | No. |
---|---|---|
4.500 | 31 | 1 |
4.510 | 342 | 1 |
4.520 | 397 | 1 |
4.530 | 370 | 1 |
4.540 | 825 | 2 |
Last trade - 15.57pm 25/11/2024 (20 minute delay) ? |
Featured News
EXL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online